These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7456014

  • 21. Lateralization of brain morphologic and cholinergic abnormalities in Alzheimer's disease.
    Moossy J, Zubenko GS, Martinez AJ, Rao GR, Kopp U, Hanin I.
    Arch Neurol; 1989 Jun; 46(6):639-42. PubMed ID: 2730376
    [Abstract] [Full Text] [Related]

  • 22. Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease.
    Palmer AM, Procter AW, Stratmann GC, Bowen DM.
    Neurosci Lett; 1986 May 15; 66(2):199-204. PubMed ID: 3014387
    [Abstract] [Full Text] [Related]

  • 23. Bilateral symmetry of cholinergic deficits in Alzheimer's disease.
    Zubenko GS, Moossy J, Hanin I, Martinez AJ, Rao GR, Kopp U.
    Arch Neurol; 1988 Mar 15; 45(3):255-9. PubMed ID: 3341949
    [Abstract] [Full Text] [Related]

  • 24. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D, Marescau B, Engelborghs S, Cremers T, Mulder J, Staufenbiel M, De Deyn PP.
    Neurochem Int; 2005 Apr 15; 46(5):409-22. PubMed ID: 15737439
    [Abstract] [Full Text] [Related]

  • 25. Neuroanatomical evidence for a cholinergic deficit in Alzheimer's disease.
    Whitehouse PJ, Struble RG, Hedreen JC, Clark AW, White CL, Parhad IM, Price DL.
    Psychopharmacol Bull; 1983 Apr 15; 19(3):437-40. PubMed ID: 6635120
    [No Abstract] [Full Text] [Related]

  • 26. Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease.
    Prohovnik I, Perl DP, Davis KL, Libow L, Lesser G, Haroutunian V.
    Neurology; 2006 Jan 10; 66(1):49-55. PubMed ID: 16401845
    [Abstract] [Full Text] [Related]

  • 27. [Effects of Chinese herb compound Naoyikang on expression of choline acetyltransferase in brain of rats with Alzheimer's disease].
    Geng JS, Zhou AL, Shi HY, Hu YE, Mao JH, Zhu Y.
    Zhongguo Zhong Yao Za Zhi; 2008 May 10; 33(9):1071-4. PubMed ID: 18652361
    [Abstract] [Full Text] [Related]

  • 28. Alzheimer's disease and the new neuroscience.
    Wortis J.
    Biol Psychiatry; 1983 Aug 10; 18(8):847-8. PubMed ID: 6137248
    [No Abstract] [Full Text] [Related]

  • 29. [Preparation and assessment of an animal model of Alzheimer's disease].
    Matsuda H, Kinuya K, Tsuji S, Terada H, Shiba K, Kojima K, Mori H, Sumiya H, Hisada K.
    Kaku Igaku; 1990 Aug 10; 27(8):883-91. PubMed ID: 2232358
    [No Abstract] [Full Text] [Related]

  • 30. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type.
    Davies P.
    Brain Res; 1979 Aug 03; 171(2):319-27. PubMed ID: 37989
    [Abstract] [Full Text] [Related]

  • 31. Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease.
    Ikonomovic MD, Abrahamson EE, Isanski BA, Wuu J, Mufson EJ, DeKosky ST.
    Arch Neurol; 2007 Sep 03; 64(9):1312-7. PubMed ID: 17846271
    [Abstract] [Full Text] [Related]

  • 32. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P.
    Funct Neurol; 1997 Sep 03; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract] [Full Text] [Related]

  • 33. Alzheimer's disease and Down's syndrome.
    Price DL, Whitehouse PJ, Struble RG, Coyle JT, Clark AW, Delong MR, Cork LC, Hedreen JC.
    Ann N Y Acad Sci; 1982 Sep 03; 396():145-64. PubMed ID: 6217772
    [No Abstract] [Full Text] [Related]

  • 34. Dementia of the Alzheimer type.
    Terry RD, Davies P.
    Annu Rev Neurosci; 1980 Sep 03; 3():77-95. PubMed ID: 6251745
    [No Abstract] [Full Text] [Related]

  • 35. Choline analogs as potential tools in developing selective animal models of central cholinergic hypofunction.
    Fisher A, Hanin I.
    Life Sci; 1980 Nov 03; 27(18):1615-34. PubMed ID: 7003285
    [No Abstract] [Full Text] [Related]

  • 36. Trophic, biochemical and functional changes in submaxillary glands and pancreas induced by chronic alcohol feeding as indirect effect mediated by parasympathetic autonomic centers.
    Perec CJ, Tiscornia OM, Baratti CM, Tumilasci OR, Dreiling DA.
    Mt Sinai J Med; 1984 Dec 03; 51(6):664-74. PubMed ID: 6335560
    [No Abstract] [Full Text] [Related]

  • 37. [Biochemical and etiopathogenic aspects of senile Alzheimer-type dementia].
    Nicolini H, Ortega H, de la Fuente JR.
    Acta Psiquiatr Psicol Am Lat; 1988 Dec 03; 34(4):343-8. PubMed ID: 3076315
    [No Abstract] [Full Text] [Related]

  • 38. Focal changes in Alzheimer's disease and cholinergic hypothesis.
    Rossor MN.
    Lancet; 1983 Aug 20; 2(8347):465. PubMed ID: 6135958
    [No Abstract] [Full Text] [Related]

  • 39. Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase.
    Fu AL, Li Q, Dong ZH, Huang SJ, Wang YX, Sun MJ.
    Neurosci Lett; 2004 Sep 30; 368(3):258-62. PubMed ID: 15364407
    [Abstract] [Full Text] [Related]

  • 40. Cholinergic markers in Alzheimer disease.
    Bartus RT, Emerich DF.
    JAMA; 1999 Dec 15; 282(23):2208-9. PubMed ID: 10605966
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.